Delivery Order SPE2DB25D3006-SPE2DB25FXKCR
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $3,380.41. This non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract action under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $19,801.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch in quantities of 30 units. The order was competitively awarded with no set-aside designation and has an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,058.19 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with performance in Conshohocken, Pennsylvania. This non-set-aside, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,622.36, represents a non-competitive set-aside contract and is scheduled for completion by August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKCRDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,077.49 by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. The contractor's place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Lidocaine patches represents a routine pharmaceutical supply transaction typical of the company's extensive portfolio of small to moderate-value orders fulfilling Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/18/25 |